What $1,000 in Medtronic (MDT) Stock 5 Years Ago Is Worth Now – The Numbers Don’t Lie

Medtronic stock had its moment—but did it deliver the gains investors hoped for?

Five years ago, you dropped a grand on MDT. Now? Let’s just say it wasn’t exactly a moonshot.

Medical devices move slow—so does the stock. While crypto was doing triple-digit gains, MDT plodded along like a pacemaker at rush hour.

Here’s the cold hard math: Your $1,000 would’ve grown to $X today (insert original data here). Not terrible… if you enjoy watching paint dry.

Bottom line: In a world of DeFi degens and AI hype trains, Medtronic remains the ‘responsible adult’ of your portfolio—reliable, unsexy, and allergic to Lambo dreams.

Image source: Getty Images.

One area of particular interest is artificial intelligence (AI), which Medtronic has been incorporating into its offerings, like many other companies. For example, it's using AI in its endoscopy equipment to help detect polyps. The company is growing, too, with fourth-quarter revenue of $8.9 billion, up 4%, and an operating profit of $6 billion for fiscal 2025, up 16% year over year.

Best of all, the company's stock seems appealingly valued, with a recent forward-looking price-to-earnings (P/E) ratio of 16, below its five-year average of 17. If you're looking for a combination of growth and income, give Medtronic some consideration for your long-term portfolio.